Vanda receives complete response letter regarding sNDA for Hetlioz for treatment of jet lag disorder Aug. 20, 2019
Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma Aug. 20, 2019
Bristol-Myers Squibb discovers receptor-interacting serine/threonine-protein kinase 1 inhibitors Aug. 20, 2019
RNA-binding protein 39 degradation inducers patented by the Dana-Farber Cancer Institute Aug. 20, 2019
RSS